LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.

Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

This was the stock's sixth consecutive day of losses.

Shares of Labcorp Holdings Inc. LH shed 1.64% to $235.78 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.22% to 5,662.89 ...

The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.

Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million ...

Daniel B. Levin, Bethany Kristovich and Colin A. Devine of Munger, Tolles & Olson LLP discuss a question before the Supreme ...

Labcorp (LH) and OPKO Health (OPK) announced that they have entered into an agreement for Labcorp to acquire select assets of BioReference ...

Transaction to extend Labcorp's leadership in oncology and expand access to the company's high-quality clinical laboratory services Through this transaction, Labcorp will acquire BioReference ...

The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.